Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19

The study brings together symptom tracking, in-home testing and in-home infusions to detect, intercept and treat COVID-19 early INDIANAPOLIS and MINNETONKA, Minn. , Dec. 4, 2020 /PRNewswire/ --   Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to